A.M. Fagan and F.H. Gage, Mechanisms of sprouting in the adult central nervous system: cellular responses in areas of terminal degeneration and reinnervation in the rat hippocampus. Neuroscience. 58(4): p. 705–725 (1994).
PubMed
CrossRef
CAS
Google Scholar
M. Frotscher, B. Heimrich, and T. Deller, Sprouting in the hippocampus is layer-specific. TINS. 20: p. 218–223 (1997).
PubMed
CAS
Google Scholar
G. Raisman and P.M. Field, A quantitative investigation of the development of collateral reinnervation after partial deafferentation of the septal nuclei. Brain Res. 50(2): p. 241–264 (1973).
PubMed
CrossRef
CAS
Google Scholar
D.I. Finkelstein, D. Stanic, C.L. Parish, D. Tomas, K. Dickson, and M.K. Flame. Axonal sprouting following lesions of the rat substantia nigra. Neuroscience. 97(1): p. 99–112 (2000).
PubMed
CrossRef
CAS
Google Scholar
P.E. Batchelor, G.T. Liberatore, J.Y. Wong, M.J. Porritt, F. Frerichs, G.A. Donnan, and D.W. Howells, Activated macrophages and microglia induce dopaminergic sprouting in the injured striatum and express brain-derived neurotrophic factor and glial cell line-derived neurotrophic factor. J Neurosci. 19(5): p. 1708–16 (1999).
PubMed
CAS
Google Scholar
V. Blanchard, P. Anglade, G. Dziewczapolski, M. Savasta, Y. Agid, and R. Raisman-Vozari, Dopaminergic sprouting in the rat striatum after partial lesion of the substantia nigra. Brain Res. 709(2): p. 319–325 (1996).
PubMed
CrossRef
CAS
Google Scholar
V. Blanchard, M. Chritin, S. Vyas, M. Savasta, C. Feuerstein, Y. Agid, F. Javoy-Agid, and R. RaismanVozari, Long-term induction of tyrosine hydroxylase expression: compensatory response to partial degeneration of the dopaminergic nigrostriatal system in the rat brain. J. Neurochem. 64(4): p. 1669–1679 (1995).
PubMed
CrossRef
CAS
Google Scholar
S.P. Onn, T.W. Berger, E.M. Stricker, and M.J. Zigmond, Effects of intraventricular 6-hydroxydopamine on the dopaminergic innervation of striatum: histochemical and neurochemical analysis. Brain Res.. 376(1): p. 8–19 (1986).
PubMed
CrossRef
CAS
Google Scholar
H.W. Cheng, J. Tong, and T.H. McNeill, Lesion-induced axon sprouting in the deafferented striatum of adult rat. Neuroscience Letters. 242(2): p. 69–72 (1998).
PubMed
CrossRef
CAS
Google Scholar
G.T. Liberatore, D.I. Finkelstein, J.Y. Wong, M.K. Home, M.J. Porritt, G.A. Donnan, and D.W. Howells, Sprouting of dopaminergic axons after striatal injury: confirmation by markers not dependent on dopamine metabolism. Exp Neurol. 159(2): p. 565–73 (1999).
PubMed
CrossRef
CAS
Google Scholar
A. Ho and M. Blum, Induction of interleukin-I associated with compensatory dopaminergic sprouting in the denervated striatum of young mice: model of aging and neurodegenerative disease. J Neurosci. 18(15): p. 5614–29 (1998).
PubMed
CAS
Google Scholar
J. Thomas, J. Wang, H. Takubo, J. Sheng, S. de Jesus, and K.S. Bankiewicz, A 6-hydroxydopamineinduced selective parkinsonian rat model: further biochemical and behavioral characterization. Exp. Neurol. 126(2): p. 159–167 (1994).
CAS
Google Scholar
C.L. Parish, Finkelstein, D.I and Home, M.K. The ultrastructure of nigrostriatal terminals following partial denervation of the substantia nigra pars compacta. in Proc. Aust. Neurosci. Soc. 2000. Melbourne, Austral ia.
Google Scholar
C. Missale, S.R. Nash, S.W. Robinson, M. Jaber, and M.G. Caron, Dopamine receptors: from structure to function. Physiol Rev. 78(1): p. 189–225 (1998).
PubMed
CAS
Google Scholar
D.M. Weiner, A.I. Levey, R.K. Sunahara, H.B. Niznik, B.F. O’Dowd, P. Seeman, and M.R. Brann, D1 and D2 dopamine receptor mRNA in rat brain. Proc Natl Acad Sci USA. 88(5): p. 1859–63 (1991).
PubMed
CrossRef
CAS
Google Scholar
C.R. Gerfen, M. Herkenham, and J. Thibault, The neostriatal mosaic: II. Patch-and matrix-directed mesostriatal dopaminergic and non-dopaminergic systems. J Neurosci. 7(12): p. 3915–3934 (1987).
PubMed
CAS
Google Scholar
A. Bjorklund and O. Lindvall, Dopamine-containing systems in the CNS. Handbook of Chemical Neuroanatomy: Classical Transmitters in the CNS, Part 1, ed. A. Bjorklund and T. Hokfelt. Vol. 2. 1984, Amsterdam: Elsevier Science Publishers. 55–122.
Google Scholar
J. Drago, P. Padungchaichot, D. Accili, and S. Fuchs, Dopamine receptors and dopamine transporter in brain function and addictive behaviors: insights from targeted mouse mutants. Dev Neurosci. 20(2–3): p. 188–203 (1998).
PubMed
CrossRef
CAS
Google Scholar
J. Drago, C.R. Gerfen, J.E. Lachowicz, H. Steiner, T.R. Hollon, P.E. Love, G.T. Ooi, A. Grinberg, E.J. Lee, S.P. Huang, P.F. Bartlett, P.A. Jose, D.R. Sibley, and H. Westphal, Altered striatal function in a mutant mouse lacking DIA dopamine receptors. Proc Natl Acad Sci U S A. 91(26): p. 12564–8 (1994).
PubMed
CrossRef
CAS
Google Scholar
J.H. Baik, R. Picetti, A. Saiardi, G. Thiriet, A. Dierich, A. Depaulis, M. Le Meur, and E. Borrelli, Parkinsonian-like locomotor impairment in mice lacking dopamine D2 receptors. Nature. 377(6548): p. 424–8 (1995).
PubMed
CrossRef
CAS
Google Scholar
C.L. Parish, D.I. Finkelstein, J. Drago, E. Borrelli, and M.K. Home, The role of dopamine receptors in regulating the size of axonal arbors. J Neurosci. 21(14): p. 5147–57. (2001).
PubMed
CAS
Google Scholar
J.R. Cooper, F.E. Bloom, and R.H. Roth, The biochemical basis of neuropharmacology. 7th ed. 1996, New York: Oxford University Press.
Google Scholar
E.R. Kandel, J.H. Schwartz, and T.M. Jessell. Principles of Neural Science. 3rd ed. 1991, New York: Elsevier.
Google Scholar
I. Creese, Dopamine receptors explained. TJiv 5: p. 40–43 (1982).
CAS
Google Scholar
A. Usiello, J.H. Baik, F. Rouge-Pont, R. Picetti, A. Dierich, M. LeMeur, P.V. Piazza, and E. Borrelli, Distinct functions of the two isoforms of dopamine D2 receptors. Nature. 408(6809): p. 199–203 (2000).
PubMed
CrossRef
CAS
Google Scholar
Z.U. Khan, P. Koulen, M. Rubinstein, D.K Grandy. and P.S. Goldman-Rakic. An astroglia-linked dopamine D2-receptor action in prefrontal cortex. Proc Vail Acad Sci USA. 98(4): p. 1964–9. (2001).
CrossRef
CAS
Google Scholar
O. Rascol, D.J. Brooks, A.D. Korczyn, P.P. De Deyn, C.E. Clarke, and A.E. Lang, A five-year study of the incidence of dyskinesia in patients with early Parkinson’s disease who were treated with ropinirole or levodopa. 056 Study Group. N Engl J Med. 342(20): p. 1484–91 (2000).
PubMed
CrossRef
CAS
Google Scholar